Recursive Partitioning Analysis Index is Predictive for Overall Survival in Patients Undergoing Spine Stereotactic Body Radiation Therapy for Spinal Metastases

医学 放射外科 黑色素瘤 核医学 肉瘤 放射治疗 内科学 外科 病理 癌症研究
作者
S.T. Chao,Shlomo A. Koyfman,N.M. Woody,L. Angelov,S. Soeder,C.A. Reddy,L. A. Rybicki,T. Djemil,Jung-Keun Suh
出处
期刊:International Journal of Radiation Oncology Biology Physics [Elsevier BV]
卷期号:78 (3): S13-S14
标识
DOI:10.1016/j.ijrobp.2010.07.073
摘要

To generate a prognostic index using recursive partitioning analysis (RPA) for patients undergoing spine stereotactic body radiation therapy (sSBRT) for spinal metastases (sMet). From an IRB-approved database of patients treated with sSBRT, 174 patients were identified treated for sMet between 2/2006 and 8/2009. Patients were treated to a median dose of 14 Gy (range: 8-24) typically in a single fraction (range: 1-5). Kaplan-Meier analysis was performed to detect any correlation between survival and histology. Histologies were divided into 3 tumor types: “favorable” included breast and prostate; “radioresistant” included renal cell, melanoma, and sarcoma; and “radiosensitive” included all other histologies. RPA was performed to identify any association of the following variables with overall survival (OS) following sSBRT: tumor type, gender, age, Karnofsky Performance Status (KPS), control of primary, extraosseous metastases, time from primary diagnosis (TPD), dose of sSBRT (<14 Gy vs. ≥14 Gy), extent of spine disease (epidural only, bone and epidural, bone only), upfront or salvage treatment, presence of paraspinal extension, and previous surgery. Median follow-up was 8.9 months (range: 0.5-48.3). Median OS time from sSBRT was 10.7 months (mos). Median OS for “favorable” histologies was 14 mo, 11.2 mo for “radioresistant” histologies, and 7.3 mos for “radiosensitive” histologies (p = 0.02). RPA analysis resulted in 3 classes (p < 0.0001, graph to be presented at meeting). Class 1 is defined as: TPD>30 mos and KPS>70; Class 2: TPD>30 mos and KPS≤70 (or) TPD≤30 mos and age < 70 yo; Class 3: TPD≤30 mos and age≥70 yo. Median OS was 21.1 mos for Class 1 (n = 59), 8.7 mos for Class 2 (n = 104), and 2.4 mos for Class 3 (n = 11). sSBRT patients treated for sMet have a wide variability in OS. We developed a RPA classification system that is predictive of OS. While many patients are treated for palliation of pain or to avoid symptomatic progression, this index may be used to predict who may benefit the most from sSBRT. Given that this proposed classification system is based on a single institution's experience with sSBRT, this index will need multi-institutional validation.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
yufanhui应助阳佟半仙采纳,获得10
刚刚
刚刚
许初完成签到,获得积分10
刚刚
1秒前
SciGPT应助黎书禾采纳,获得10
2秒前
3秒前
李龙章完成签到,获得积分20
3秒前
mou完成签到 ,获得积分10
3秒前
小二郎应助王sir采纳,获得10
4秒前
SCISSH完成签到 ,获得积分10
5秒前
孙Tuan发布了新的文献求助10
5秒前
5秒前
5秒前
ncjdoi发布了新的文献求助10
5秒前
隐形蛋挞完成签到,获得积分10
5秒前
景三完成签到,获得积分10
6秒前
6秒前
7wnc发布了新的文献求助10
7秒前
共享精神应助王小玮采纳,获得10
7秒前
qqqxl发布了新的文献求助10
7秒前
8秒前
开心的双双完成签到,获得积分20
9秒前
樱桃汽水怪兽完成签到,获得积分10
9秒前
胡萝卜发布了新的文献求助10
9秒前
略略略应助视野胤采纳,获得20
10秒前
FFGC发布了新的文献求助10
10秒前
11秒前
传奇3应助ncjdoi采纳,获得10
11秒前
11秒前
sherry完成签到 ,获得积分10
12秒前
情怀应助鱼咬羊采纳,获得10
12秒前
孙Tuan完成签到,获得积分10
12秒前
海东来应助哈哈哈哈采纳,获得150
12秒前
科研通AI2S应助许初采纳,获得10
13秒前
13秒前
芒果完成签到 ,获得积分10
14秒前
豆豆发布了新的文献求助10
14秒前
14秒前
lovexy完成签到,获得积分10
14秒前
八一完成签到,获得积分10
14秒前
高分求助中
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
Effective Learning and Mental Wellbeing 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3974797
求助须知:如何正确求助?哪些是违规求助? 3519250
关于积分的说明 11197623
捐赠科研通 3255405
什么是DOI,文献DOI怎么找? 1797769
邀请新用户注册赠送积分活动 877156
科研通“疑难数据库(出版商)”最低求助积分说明 806202